author_facet Culman, Juraj
Wiegand, Brigitte
Spitznagel, Heidi
Klee, Sabine
Unger, Thomas
Culman, Juraj
Wiegand, Brigitte
Spitznagel, Heidi
Klee, Sabine
Unger, Thomas
author Culman, Juraj
Wiegand, Brigitte
Spitznagel, Heidi
Klee, Sabine
Unger, Thomas
spellingShingle Culman, Juraj
Wiegand, Brigitte
Spitznagel, Heidi
Klee, Sabine
Unger, Thomas
British Journal of Pharmacology
Effects of the tachykinin NK1 receptor antagonist, RP 67580, on central cardiovascular and behavioural effects of substance P, neurokinin A and neurokinin B
Pharmacology
author_sort culman, juraj
spelling Culman, Juraj Wiegand, Brigitte Spitznagel, Heidi Klee, Sabine Unger, Thomas 0007-1188 1476-5381 Wiley Pharmacology http://dx.doi.org/10.1111/j.1476-5381.1995.tb13348.x <jats:p>1 We have investigated the effects of the non‐peptide NK<jats:sub>1</jats:sub> tachykinin receptor antagonist, RP 67580, and its inactive enantiomer, RP 68651, on the cardiovascular and behavioural responses to substance P (SP), neurokinin A (NKA) and neurokinin B (NKB) injected intracerebroventricularly (i.c.v.) in conscious rats.</jats:p><jats:p>2 The SP and NKA (25 pmol)‐induced increases in blood pressure (BP) and heart rate (HR) were of the same magnitude. The cardiovascular responses to both peptides were associated with excessive grooming behaviour and wet dog shakes (WDS). Relative to SP, NKA was weaker in inducing hindquarter grooming (HG), but more effective in eliciting WDS. The cardiovascular response to NKB (50 pmol) comprised an increase in BP and HR, while the behavioural response was weak.</jats:p><jats:p>3 RP 67580 (100 pmol), injected 10 or 30 min prior to SP, effectively inhibited the cardiovascular and behavioural responses to the peptide whereas lower doses were ineffective. Pretreatment with 500 pmol of RP 67580, 10 or 30 min prior to SP, reduced the BP response. Of the behavioural manifestations, only face washing was attenuated when the antagonist was injected 10 min before SP. At 2500 pmol, the antagonist exaggerated the BP response to the peptide without affecting the behavioural response. RP 68651 (100 or 2500 pmol) did not modify the central responses to SP.</jats:p><jats:p>4 Neither RP 67580 nor RP 68651 (100 pmol), affected the cardiovascular and behavioural responses to NKA or NKB.</jats:p><jats:p>5 Our results indicate that RP 67580 is a selective and high affinity antagonist at central NK<jats:sub>1</jats:sub> tachykinin receptors in the rat.</jats:p> Effects of the tachykinin NK<sub>1</sub> receptor antagonist, RP 67580, on central cardiovascular and behavioural effects of substance P, neurokinin A and neurokinin B British Journal of Pharmacology
doi_str_mv 10.1111/j.1476-5381.1995.tb13348.x
facet_avail Online
Free
finc_class_facet Chemie und Pharmazie
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9qLjE0NzYtNTM4MS4xOTk1LnRiMTMzNDgueA
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9qLjE0NzYtNTM4MS4xOTk1LnRiMTMzNDgueA
institution DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
imprint Wiley, 1995
imprint_str_mv Wiley, 1995
issn 0007-1188
1476-5381
issn_str_mv 0007-1188
1476-5381
language English
mega_collection Wiley (CrossRef)
match_str culman1995effectsofthetachykininnk1receptorantagonistrp67580oncentralcardiovascularandbehaviouraleffectsofsubstancepneurokininaandneurokininb
publishDateSort 1995
publisher Wiley
recordtype ai
record_format ai
series British Journal of Pharmacology
source_id 49
title Effects of the tachykinin NK1 receptor antagonist, RP 67580, on central cardiovascular and behavioural effects of substance P, neurokinin A and neurokinin B
title_unstemmed Effects of the tachykinin NK1 receptor antagonist, RP 67580, on central cardiovascular and behavioural effects of substance P, neurokinin A and neurokinin B
title_full Effects of the tachykinin NK1 receptor antagonist, RP 67580, on central cardiovascular and behavioural effects of substance P, neurokinin A and neurokinin B
title_fullStr Effects of the tachykinin NK1 receptor antagonist, RP 67580, on central cardiovascular and behavioural effects of substance P, neurokinin A and neurokinin B
title_full_unstemmed Effects of the tachykinin NK1 receptor antagonist, RP 67580, on central cardiovascular and behavioural effects of substance P, neurokinin A and neurokinin B
title_short Effects of the tachykinin NK1 receptor antagonist, RP 67580, on central cardiovascular and behavioural effects of substance P, neurokinin A and neurokinin B
title_sort effects of the tachykinin nk<sub>1</sub> receptor antagonist, rp 67580, on central cardiovascular and behavioural effects of substance p, neurokinin a and neurokinin b
topic Pharmacology
url http://dx.doi.org/10.1111/j.1476-5381.1995.tb13348.x
publishDate 1995
physical 1310-1316
description <jats:p>1 We have investigated the effects of the non‐peptide NK<jats:sub>1</jats:sub> tachykinin receptor antagonist, RP 67580, and its inactive enantiomer, RP 68651, on the cardiovascular and behavioural responses to substance P (SP), neurokinin A (NKA) and neurokinin B (NKB) injected intracerebroventricularly (i.c.v.) in conscious rats.</jats:p><jats:p>2 The SP and NKA (25 pmol)‐induced increases in blood pressure (BP) and heart rate (HR) were of the same magnitude. The cardiovascular responses to both peptides were associated with excessive grooming behaviour and wet dog shakes (WDS). Relative to SP, NKA was weaker in inducing hindquarter grooming (HG), but more effective in eliciting WDS. The cardiovascular response to NKB (50 pmol) comprised an increase in BP and HR, while the behavioural response was weak.</jats:p><jats:p>3 RP 67580 (100 pmol), injected 10 or 30 min prior to SP, effectively inhibited the cardiovascular and behavioural responses to the peptide whereas lower doses were ineffective. Pretreatment with 500 pmol of RP 67580, 10 or 30 min prior to SP, reduced the BP response. Of the behavioural manifestations, only face washing was attenuated when the antagonist was injected 10 min before SP. At 2500 pmol, the antagonist exaggerated the BP response to the peptide without affecting the behavioural response. RP 68651 (100 or 2500 pmol) did not modify the central responses to SP.</jats:p><jats:p>4 Neither RP 67580 nor RP 68651 (100 pmol), affected the cardiovascular and behavioural responses to NKA or NKB.</jats:p><jats:p>5 Our results indicate that RP 67580 is a selective and high affinity antagonist at central NK<jats:sub>1</jats:sub> tachykinin receptors in the rat.</jats:p>
container_issue 6
container_start_page 1310
container_title British Journal of Pharmacology
container_volume 114
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792337154196635660
geogr_code not assigned
last_indexed 2024-03-01T15:10:14.833Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Effects+of+the+tachykinin+NK1+receptor+antagonist%2C+RP+67580%2C+on+central+cardiovascular+and+behavioural+effects+of+substance+P%2C+neurokinin+A+and+neurokinin+B&rft.date=1995-03-01&genre=article&issn=1476-5381&volume=114&issue=6&spage=1310&epage=1316&pages=1310-1316&jtitle=British+Journal+of+Pharmacology&atitle=Effects+of+the+tachykinin+NK%3Csub%3E1%3C%2Fsub%3E+receptor+antagonist%2C+RP+67580%2C+on+central+cardiovascular+and+behavioural+effects+of+substance+P%2C+neurokinin+A+and+neurokinin+B&aulast=Unger&aufirst=Thomas&rft_id=info%3Adoi%2F10.1111%2Fj.1476-5381.1995.tb13348.x&rft.language%5B0%5D=eng
SOLR
_version_ 1792337154196635660
author Culman, Juraj, Wiegand, Brigitte, Spitznagel, Heidi, Klee, Sabine, Unger, Thomas
author_facet Culman, Juraj, Wiegand, Brigitte, Spitznagel, Heidi, Klee, Sabine, Unger, Thomas, Culman, Juraj, Wiegand, Brigitte, Spitznagel, Heidi, Klee, Sabine, Unger, Thomas
author_sort culman, juraj
container_issue 6
container_start_page 1310
container_title British Journal of Pharmacology
container_volume 114
description <jats:p>1 We have investigated the effects of the non‐peptide NK<jats:sub>1</jats:sub> tachykinin receptor antagonist, RP 67580, and its inactive enantiomer, RP 68651, on the cardiovascular and behavioural responses to substance P (SP), neurokinin A (NKA) and neurokinin B (NKB) injected intracerebroventricularly (i.c.v.) in conscious rats.</jats:p><jats:p>2 The SP and NKA (25 pmol)‐induced increases in blood pressure (BP) and heart rate (HR) were of the same magnitude. The cardiovascular responses to both peptides were associated with excessive grooming behaviour and wet dog shakes (WDS). Relative to SP, NKA was weaker in inducing hindquarter grooming (HG), but more effective in eliciting WDS. The cardiovascular response to NKB (50 pmol) comprised an increase in BP and HR, while the behavioural response was weak.</jats:p><jats:p>3 RP 67580 (100 pmol), injected 10 or 30 min prior to SP, effectively inhibited the cardiovascular and behavioural responses to the peptide whereas lower doses were ineffective. Pretreatment with 500 pmol of RP 67580, 10 or 30 min prior to SP, reduced the BP response. Of the behavioural manifestations, only face washing was attenuated when the antagonist was injected 10 min before SP. At 2500 pmol, the antagonist exaggerated the BP response to the peptide without affecting the behavioural response. RP 68651 (100 or 2500 pmol) did not modify the central responses to SP.</jats:p><jats:p>4 Neither RP 67580 nor RP 68651 (100 pmol), affected the cardiovascular and behavioural responses to NKA or NKB.</jats:p><jats:p>5 Our results indicate that RP 67580 is a selective and high affinity antagonist at central NK<jats:sub>1</jats:sub> tachykinin receptors in the rat.</jats:p>
doi_str_mv 10.1111/j.1476-5381.1995.tb13348.x
facet_avail Online, Free
finc_class_facet Chemie und Pharmazie
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTExMS9qLjE0NzYtNTM4MS4xOTk1LnRiMTMzNDgueA
imprint Wiley, 1995
imprint_str_mv Wiley, 1995
institution DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161
issn 0007-1188, 1476-5381
issn_str_mv 0007-1188, 1476-5381
language English
last_indexed 2024-03-01T15:10:14.833Z
match_str culman1995effectsofthetachykininnk1receptorantagonistrp67580oncentralcardiovascularandbehaviouraleffectsofsubstancepneurokininaandneurokininb
mega_collection Wiley (CrossRef)
physical 1310-1316
publishDate 1995
publishDateSort 1995
publisher Wiley
record_format ai
recordtype ai
series British Journal of Pharmacology
source_id 49
spelling Culman, Juraj Wiegand, Brigitte Spitznagel, Heidi Klee, Sabine Unger, Thomas 0007-1188 1476-5381 Wiley Pharmacology http://dx.doi.org/10.1111/j.1476-5381.1995.tb13348.x <jats:p>1 We have investigated the effects of the non‐peptide NK<jats:sub>1</jats:sub> tachykinin receptor antagonist, RP 67580, and its inactive enantiomer, RP 68651, on the cardiovascular and behavioural responses to substance P (SP), neurokinin A (NKA) and neurokinin B (NKB) injected intracerebroventricularly (i.c.v.) in conscious rats.</jats:p><jats:p>2 The SP and NKA (25 pmol)‐induced increases in blood pressure (BP) and heart rate (HR) were of the same magnitude. The cardiovascular responses to both peptides were associated with excessive grooming behaviour and wet dog shakes (WDS). Relative to SP, NKA was weaker in inducing hindquarter grooming (HG), but more effective in eliciting WDS. The cardiovascular response to NKB (50 pmol) comprised an increase in BP and HR, while the behavioural response was weak.</jats:p><jats:p>3 RP 67580 (100 pmol), injected 10 or 30 min prior to SP, effectively inhibited the cardiovascular and behavioural responses to the peptide whereas lower doses were ineffective. Pretreatment with 500 pmol of RP 67580, 10 or 30 min prior to SP, reduced the BP response. Of the behavioural manifestations, only face washing was attenuated when the antagonist was injected 10 min before SP. At 2500 pmol, the antagonist exaggerated the BP response to the peptide without affecting the behavioural response. RP 68651 (100 or 2500 pmol) did not modify the central responses to SP.</jats:p><jats:p>4 Neither RP 67580 nor RP 68651 (100 pmol), affected the cardiovascular and behavioural responses to NKA or NKB.</jats:p><jats:p>5 Our results indicate that RP 67580 is a selective and high affinity antagonist at central NK<jats:sub>1</jats:sub> tachykinin receptors in the rat.</jats:p> Effects of the tachykinin NK<sub>1</sub> receptor antagonist, RP 67580, on central cardiovascular and behavioural effects of substance P, neurokinin A and neurokinin B British Journal of Pharmacology
spellingShingle Culman, Juraj, Wiegand, Brigitte, Spitznagel, Heidi, Klee, Sabine, Unger, Thomas, British Journal of Pharmacology, Effects of the tachykinin NK1 receptor antagonist, RP 67580, on central cardiovascular and behavioural effects of substance P, neurokinin A and neurokinin B, Pharmacology
title Effects of the tachykinin NK1 receptor antagonist, RP 67580, on central cardiovascular and behavioural effects of substance P, neurokinin A and neurokinin B
title_full Effects of the tachykinin NK1 receptor antagonist, RP 67580, on central cardiovascular and behavioural effects of substance P, neurokinin A and neurokinin B
title_fullStr Effects of the tachykinin NK1 receptor antagonist, RP 67580, on central cardiovascular and behavioural effects of substance P, neurokinin A and neurokinin B
title_full_unstemmed Effects of the tachykinin NK1 receptor antagonist, RP 67580, on central cardiovascular and behavioural effects of substance P, neurokinin A and neurokinin B
title_short Effects of the tachykinin NK1 receptor antagonist, RP 67580, on central cardiovascular and behavioural effects of substance P, neurokinin A and neurokinin B
title_sort effects of the tachykinin nk<sub>1</sub> receptor antagonist, rp 67580, on central cardiovascular and behavioural effects of substance p, neurokinin a and neurokinin b
title_unstemmed Effects of the tachykinin NK1 receptor antagonist, RP 67580, on central cardiovascular and behavioural effects of substance P, neurokinin A and neurokinin B
topic Pharmacology
url http://dx.doi.org/10.1111/j.1476-5381.1995.tb13348.x